NRSN: neurosense-tx.com Cash Calculated per Single Share

NeuroSense Therapeutics Ltd. - graphic logo of issuer NRSN

The development of combined treatments for BAS at the clinical stage requires strict liquidity control for NeuroSense Therapeutics (NRSN). The success of the business model relies on the efficacy of the PrimeC drug and patent protection. The net cash position per share in the GURU.Markets interface is illustrated by this chart, where the 0.00 level reflects the current magnitude. However, the absence of approved products coupled with capital burn creates serious survival risks for the company.

NeuroSense Therapeutics Ltd (NRSN) - Cash per Share from 07/04/2022 to 11/20/2026

Comprehensive metric breakdowns and analytics for NeuroSense Therapeutics, Ltd. (NRSN)

- cash availability and cash flow indicators:
Comprehensive company analysis:NeuroSense Therapeutics Ltd. (NRSN)
Flagship merchandise of NeuroSense Therapeutics Ltd

Liquidity determines the financial stability of a business during periods of high asset volatility. This metric is calculated as the ratio of highly liquid assets to the total number of shares, revealing the real value of an owner's stake. For NeuroSense Therapeutics (NRSN), this is a critical metric that ensures the funding of multi-year clinical trials for neurodegenerative drugs. The non-cyclical nature of the business makes the cash reserve the primary guarantor of operational activity. The trend of the cash cushion per share allows for an assessment of the company's margin of safety ahead of new testing phases.

Key competitors

Biogen Corp (BIIB) - Cash Funds Calculated per Share|Cash per Share NBIX|RGC - Cash on Hand per Share|Cash Funds per Share Axsome Therapeutics AXSM|Cash per Share ACADIA Pharmaceuticals Inc. ACAD|xenon-pharma.com - Cash per Share|Cash on Hand per Share Viking Therapeutics|SUPN: Cash per Share|Catalyst Pharmaceuticals (CPRX) - Cash per Share|Cash per Single Share DNLI|Cash Funds per Single Share HRMY (Harmony Biosciences Holdings, Inc.)|Cash Funds per Share Biohaven Ltd. (BHVN)|Cash Calculated per Single Share AMLX|Cash Funds per Share trevitherapeutics.com TRVI|PRAX - Cash per Single Share|Anavex Life Sciences Corp - Cash per Share|Cash on Hand per Share CeriBell Corp|Prothena Corporation PLC (PRTA) - Cash Funds per Share|Alector Therapeutics - Amount of Cash per Share|Cash Funds per Share Annexon Biosciences|Cash on Hand per Share omeros.com OMER|Cash Funds per Share Neurogene (NGNE)|Cash Funds Calculated per Share AC Immune S.A.|Cash per Share VYGR (Voyager Therapeutics Inc)|Amount of Cash per Share NMRA|scilexholding.com - Cash per Share|TVGN (tevogen.com) - Cash Funds per Single Share|ACOG: Cash per Share|CGTX: Cash Calculated per Single Share|Cash Funds per Share Inhibikase Therapeutics|Cash Funds per Single Share SAVA (Cassava)|Cash Funds per Share Assertio Therapeutics (ASRT)|Coya Therapeutics - Cash Funds per Single Share|VistaGen Therapeutics, Inc. - Cash per Single Share|ovidrx.com (OVID) - Cash on Hand per Share|ABOS: Cash per Single Share|Cash on Hand per Share CervoMed Inc|alteritytherapeutics.com (ATHE) - Cash Funds per Share|Cash per Single Share Clene Nanomedicine|Cash per Single Share PEPG|Cash on Hand per Share Jupiter Neurosciences JUNS|Cash Funds per Share Relmada (RLMD)|Cash Funds Calculated per Share Annovis Bio, Inc.|Cash per Share GRCE (Grace Tx)|Firefly Neuroscience, Inc (AIFF) - Cash on Hand per Share|KLTO - Cash Funds per Share|RVPH: Cash Funds per Share|MTVA: Cash per Share|NRXS - Cash Funds Calculated per Share|HSDT (Helius Medical Technologies Inc.) - Cash per Share|Cash on Hand per Share Passage Bio PASG|Cash Funds per Share Neuphoria (NEUP)|Cash per Share Minerva Neurosciences Corp (NERV)|Cash Funds per Share Athira ATHA|Cash per Share Addex ADXN|Alzamend - Cash per Share|Cash on Hand per Share Cyclerion Therapeutics, Inc.|Protagenic Therapeutics (PTIX) - Cash Funds per Share|KTTA: Cash Calculated per Single Share|Cash per Single Share CRGT|Avenue Therapeutics, Inc - Cash Money per Share|Cash Funds per Share Brainstorm Cell (BCLI)|CARA: Cash Money per Share|Chromocell Therapeutics Corp. - Cash per Single Share|Cash Funds Calculated per Share Eliem (ELYM)|ITCI: Cash per Single Share|Amount of Cash per Share LBPH (Longboard)|marinuspharma.com (MRNS) - Cash Funds per Share|NKGN - Cash Funds Calculated per Share|NRBO (neurobopharma.com) - Cash per Share|Sage Therapeutics (SAGE) - Cash Funds Calculated per Share|Cash per Single Share SNPX (Synaptogenix, Inc.)|TRVN - Cash on Hand per Share|Cash per Share VIGL (Vigil Neuro)|WENA: Cash Funds per Single Share|CERE - Cash Funds per Share